Anika Therapeutics Inc (ANIK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ANIK Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Anika Therapeutics Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent38.41
Marketable Securities, Current SH0.00
Cash & Short-term Investments38.00
Accounts receivable29.06
Inventories28.57
Prepaid Expense And Other Assets Current3.15
Total Current Assets99.19
Equipment/Property/Plant Net94.33
Goodwill net7.83
Intangible Assets1.65
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset25.43
Total Assets183.47
Liabilities
Accounts Payable, Current AC6.24
Accrued Liabilities And Other Liabilities7.54
Other Liabilities, Current4.44
Deferred Revenue, Current DE3.94
Total Current Liabilities22.15
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent1.59
Other liabilities, Noncurrent22.46
Operating Lease Liability Noncurrent23.79
Total Liabilities46.19
Stockholders' Equity
Common Stock Value0.13
Additional Paid In Capital Common Stock83.44
Retained Earnings / Accumulated Deficit59.04
Accumulated Other Comprehensive Income-5.33
Other Equity-5.33
Common Stockholder's Equity137.28
Total Stockholder's Equity137.28
Liabilities & Stockholder's Equity183.47
4 historic quarters locked

Sign in to unlock the full Anika Therapeutics Inc balance sheet history.

About Anika Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001171843-26-005012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.